AHI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.410170E-01
Normal-vs-Stage2
6.032400E-01
Normal-vs-Stage3
1.345590E-01
Normal-vs-Stage4
2.624800E-01
Stage1-vs-Stage2
2.268400E-01
Stage1-vs-Stage3
6.725700E-02
Stage1-vs-Stage4
4.373000E-01
Stage2-vs-Stage3
1.194630E-01
Stage2-vs-Stage4
6.257200E-01
Stage3-vs-Stage4
4.433600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.385200E-01
Normal-vs-AfricanAmerican
1.609830E-01
Normal-vs-Asian
8.201400E-01
Caucasian-vs-AfricanAmerican
5.459000E-01
Caucasian-vs-Asian
1.410600E-01
AfricanAmerican-vs-Asian
8.850100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.385000E-01
Normal-vs-Female
5.418400E-01
Male-vs-Female
7.859600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.399800E-01
Normal-vs-Age(41-60Yrs)
3.862000E-01
Normal-vs-Age(61-80Yrs)
6.286800E-01
Normal-vs-Age(81-100Yrs)
8.162400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.914200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.766000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.894160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.188830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.795370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.527800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.380600E-01
Normal-vs-Daily Drinker
8.524200E-01
Normal-vs-Weekly Drinker
4.571800E-01
Normal-vs-Occasional Drinker
6.029500E-02
Normal-vs-Social Drinker
1.448780E-01
Non Drinker-vs-Daily Drinker
9.425600E-01
Non Drinker-vs-Weekly Drinker
6.369600E-01
Non Drinker-vs-Occasional Drinker
9.544400E-02
Non Drinker-vs-Social Drinker
2.489800E-01
Daily Drinker-vs-Weekly Drinker
6.598800E-01
Daily Drinker-vs-Occasional Drinker
1.031990E-01
Daily Drinker-vs-Social Drinker
2.419000E-01
Weekly Drinker-vs-Occasional Drinker
1.315760E-01
Weekly Drinker-vs-Social Drinker
3.620400E-01
Occasional Drinker-vs-Social Drinker
4.653000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.677800E-01
Normal-vs-Grade 2
2.113000E-01
Normal-vs-Grade 3
1.782410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.265700E-02
Grade 1-vs-Grade 3
1.933870E-02
Grade 1-vs-Grade 4
2.677800E-01
Grade 2-vs-Grade 3
5.408400E-01
Grade 2-vs-Grade 4
2.113000E-01
Grade 3-vs-Grade 4
1.782410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.501200E-01
Normal-vs-NonDiabetic
5.645200E-01
Diabetic-vs-NonDiabetic
2.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.558600E-01
Normal-vs-NoPancreatitis
6.164400E-01
Pancreatitis-vs-NoPancreatitis
4.210800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.044300E-02
Normal-vs-N1
6.040400E-01
N0-vs-N1
6.223800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.755800E-01
Normal-vs-TP53-NonMutant
9.70989999999894E-05
TP53-Mutant-vs-TP53-NonMutant
1.89551999999482E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
